ZANNA, Ines
 Distribuzione geografica
Continente #
NA - Nord America 653
EU - Europa 109
AS - Asia 40
OC - Oceania 1
Totale 803
Nazione #
US - Stati Uniti d'America 650
IT - Italia 41
CN - Cina 18
DE - Germania 13
SG - Singapore 11
SE - Svezia 10
GB - Regno Unito 9
RO - Romania 9
RU - Federazione Russa 9
IE - Irlanda 4
IN - India 4
BE - Belgio 3
CA - Canada 3
UA - Ucraina 3
AT - Austria 2
HK - Hong Kong 2
IR - Iran 2
AU - Australia 1
BD - Bangladesh 1
CH - Svizzera 1
DK - Danimarca 1
FI - Finlandia 1
FR - Francia 1
GR - Grecia 1
KR - Corea 1
NL - Olanda 1
UZ - Uzbekistan 1
Totale 803
Città #
Fairfield 97
Chandler 82
Ashburn 67
Woodbridge 55
Wilmington 44
Seattle 35
Houston 34
Cambridge 31
Ann Arbor 26
Altamura 18
Des Moines 18
Medford 12
Lawrence 10
Princeton 10
Singapore 10
Dearborn 8
San Diego 7
Munich 6
Nanjing 6
Falls Church 5
Rome 5
Saint Petersburg 5
Beijing 4
Dublin 4
Ludwigshafen am Rhein 4
Palermo 4
Phoenix 4
Brussels 3
Santa Fe 3
Berlin 2
Boardman 2
Changsha 2
Kumar 2
London 2
Mazara del Vallo 2
Nanchang 2
New York 2
Norwalk 2
Orange 2
Shenyang 2
Toronto 2
Venice 2
Vienna 2
Alexandria 1
Andover 1
Boston 1
Central 1
Copenhagen 1
Groningen 1
Hebei 1
Helsinki 1
Kilburn 1
New Orleans 1
Pune 1
San Giovanni Rotondo 1
Seongnam 1
Southwark 1
Sydney 1
Tappahannock 1
Tehran 1
Tianjin 1
Tulsa 1
Wandsworth 1
Washington 1
Winnipeg 1
Totale 667
Nome #
Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy 126
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: Results from a multicenter study in Italy 116
Association of SULT1A1 Arg213His polymorphism with male breast cancer risk: results from a multicenter study in Italy 109
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene 103
Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 87
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study 78
DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study 67
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype 63
Prognostic significance of p16INK4a alterations and 9p21 loss of heterozigosity in locally advanced laryngeal squamous cell carcinoma 60
Hereditary common cancers: Molecular and clinical genetics 44
Totale 853
Categoria #
all - tutte 3.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020171 0 0 6 31 23 31 18 20 19 10 10 3
2020/2021151 6 5 7 8 52 4 6 10 11 23 7 12
2021/2022139 8 20 8 8 2 8 10 9 13 21 10 22
2022/2023233 29 49 8 21 24 30 12 20 31 0 7 2
2023/202472 5 7 2 17 0 10 13 5 2 1 0 10
2024/20255 1 3 1 0 0 0 0 0 0 0 0 0
Totale 853